HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Personal-Care Industry Leaders Issue Call For Green Chemistry Solutions

This article was originally published in The Rose Sheet

Executive Summary

J&J, P&G and other members of the Green Chemistry & Commerce Council (GC3) have issued a list of green chemistry technology needs for formulating personal-care and household products to guide submissions to a competition for innovative startups. Winners will present before potential development partners at a networking event in May 2018.

You may also be interested in...



GC3 Announces Preservative Challenge Winners; Sponsors Exploring Partnership Possibilities

Avisco, a biotech startup focused on the antimicrobial properties of the Inula viscosa plant, and IMD Natural Solutions, whose INS Glycolipid mushroom extract purportedly is “up to 80 times more effective than traditional preservatives,” are among winners named Aug. 6 by GC3.

GC3 Preservatives Challenge: Winning Innovations To Be Decided By Month’s End

Leading manufacturers and chemical suppliers are in direct discussions with seven semi-finalists in the GC3 competition – aimed at surfacing early-stage preservative innovations with potential applications in the personal-care and household products sectors – with final judging now in sight.

CIR To Hear From P&G Expert With Parabens Re-Review Pending

George Daston, Victor Mills Society research fellow at Procter & Gamble, will help the Cosmetic Ingredient Review Expert Panel make sense of recently received developmental and reproductive toxicity (DART) findings as it proceeds with a re-review of parabens' safety

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121386

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel